Here are five important articles from the past week you might have missed:
Europe approves first gene therapy for retinal dystrophy
On Nov. 23, the European Commission approved the first gene therapy for the treatment of inherited retinal disease related to a mutation of the RPE65 gene. Luxturna will be authorized in all 28 EU member states as well as Norway, Iceland and Lichtenstein. Read more.
AcuFocus receives FDA approval for IC-8 clinical study
AcuFocus received approval for an investigational device exemption from the FDA to conduct a (Read more...)
Uncategorized